GBCS (Selectis Health) Piotroski F-Score: 5 (As of Jun. 25, 2026) — Near Median


GBCS Selectis Health Inc GBCS
45 GF Score
Price $5.25
GF Value $2.14
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Selectis Health Piotroski F-Score?

Selectis Health GBCS -2.78% 45 Piotroski F-Score is 5 as of Jun. 25, 2026, which is at its 10-year median of 5.00. GuruFocus rates GBCS with a GF Score™ of 45/100 and a GF Value™ of $2.14 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 651 Healthcare Providers & Services companies, Selectis Health ranks better than 54.38% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Selectis Health has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Selectis Health's Piotroski F-Score or its related term are showing as below:

GBCS' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 8
Current: 5

During the past 13 years, the highest Piotroski F-Score of Selectis Health was 8. The lowest was 2. And the median was 5.

Selectis Health  (OTCPK:GBCS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Selectis Health Piotroski F-Score Related Terms


Selectis Health Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Selectis Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Selectis Health Piotroski F-Score Chart

Selectis Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 4.00 5.00 5.00 8.00

Selectis Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 5.00 7.00 8.00 5.00

GBCS vs AMS, BICX, NUMIF: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Selectis Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Selectis Health Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Selectis Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Selectis Health's Piotroski F-Score falls into.


GBCS
45GF Score
Selectis Health Inc GBCS
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -0.308 + 0.752 + -0.804 + 6.526 = $6.17 Mil.
Cash Flow from Operations was -0.077 + 0.28 + 0.644 + -2.29 = $-1.44 Mil.
Revenue was 10.441 + 10.84 + 9.673 + 7.289 = $38.24 Mil.
Gross Profit was 2.285 + 2.321 + 2.67 + 1.221 = $8.50 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(34.543 + 33.638 + 33.264 + 32.578 + 30.012) / 5 = $32.807 Mil.
Total Assets at the begining of this year (Mar25) was $34.54 Mil.
Long-Term Debt & Capital Lease Obligation was $13.33 Mil.
Total Current Assets was $9.82 Mil.
Total Current Liabilities was $16.32 Mil.
Net Income was 0.794 + -1.607 + -0.576 + -0.656 = $-2.05 Mil.

Revenue was 9.585 + 10.016 + 10.398 + 10.487 = $40.49 Mil.
Gross Profit was 2.168 + 2.443 + 2.531 + 2.406 = $9.55 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(39.557 + 36.73 + 33.929 + 33.447 + 34.543) / 5 = $35.6412 Mil.
Total Assets at the begining of last year (Mar24) was $39.56 Mil.
Long-Term Debt & Capital Lease Obligation was $19.01 Mil.
Total Current Assets was $4.75 Mil.
Total Current Liabilities was $21.52 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Selectis Health's current Net Income (TTM) was 6.17. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Selectis Health's current Cash Flow from Operations (TTM) was -1.44. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=6.166/34.543
=0.17850216

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-2.045/39.557
=-0.05169755

Selectis Health's return on assets of this year was 0.17850216. Selectis Health's return on assets of last year was -0.05169755. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Selectis Health's current Net Income (TTM) was 6.17. Selectis Health's current Cash Flow from Operations (TTM) was -1.44. ==> -1.44 <= 6.17 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=13.328/32.807
=0.40625476

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=19.006/35.6412
=0.53325926

Selectis Health's gearing of this year was 0.40625476. Selectis Health's gearing of last year was 0.53325926. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=9.823/16.318
=0.60197328

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=4.745/21.518
=0.22051306

Selectis Health's current ratio of this year was 0.60197328. Selectis Health's current ratio of last year was 0.22051306. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Selectis Health's number of shares in issue this year was 3.443. Selectis Health's number of shares in issue last year was 3.067. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=8.497/38.243
=0.22218445

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=9.548/40.486
=0.23583461

Selectis Health's gross margin of this year was 0.22218445. Selectis Health's gross margin of last year was 0.23583461. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=38.243/34.543
=1.10711287

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=40.486/39.557
=1.0234851

Selectis Health's asset turnover of this year was 1.10711287. Selectis Health's asset turnover of last year was 1.0234851. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+1+0+1+1+0+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Selectis Health has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Selectis Health (GBCS) has a Piotroski F-Score of 5 as of Jun. 25, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Selectis Health and its competitors. This is near median its historical median of 5.00. Over the past decade, Selectis Health's Piotroski F-Score has ranged from 2.00 to 8.00. According to the industry distribution chart, Selectis Health ranks #297 out of 651 companies in the Healthcare Providers & Services industry, placing it in the top 45.6%.
Is Selectis Health's Piotroski F-Score too high?
Selectis Health's current Piotroski F-Score of 5 is near median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Selectis Health's value of 5 is 0% at this industry median. Based on the distribution chart, Selectis Health ranks #297 out of 651 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Selectis Health has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selectis Health's Piotroski F-Score compare to AMS and BICX?
According to the Healthcare Providers & Services industry distribution chart, Selectis Health ranks #297 out of 651 companies for Piotroski F-Score. This puts Selectis Health in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Selectis Health's value of 5 is 0% at this benchmark. Historically, Selectis Health's own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Selectis Health has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Selectis Health's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Selectis Health and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selectis Health's current Piotroski F-Score is 5, which is near median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selectis Health stock overvalued right now?
Based on GuruFocus' analysis, Selectis Health (GBCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.14, compared to a current price of $5.25 — trading 145.3% above its estimated fair value. The current Piotroski F-Score is 5, which is near median its 10-year median of 5.00 and 0% at the Healthcare Providers & Services industry median of 5.00. Selectis Health's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Selectis Health (GBCS), the current Piotroski F-Score is 5 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Selectis Health (GBCS) Overvalued in 2026?

Based on GuruFocus' analysis, Selectis Health stock appears to be overvalued. The current stock price of $5.25 is trading 145.3% above its estimated GF Value™ of $2.14. GuruFocus considers Selectis Health to be Significantly Overvalued.

Key valuation signals for GBCS:

  • Piotroski F-Score: 5 (near median its 10-year median of 5.00)
  • GF Value™: $2.14 vs. price of $5.25 (145.3% above fair value)
  • GF Score™: 45/100 with 4 warning signs
  • Industry Position: 0% at the Healthcare Providers & Services median (#297 of 651)

No single metric tells the full story. See the GBCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Selectis Health Business Description

Address 600 17th Street, Suite 284, Denver, CO, USA, 80202
Selectis Health Inc owns and operates medical care facilities in the healthcare industry. The company acquires, develops, leases, and manages healthcare real estate and provides healthcare operations through its wholly-owned subsidiaries. The portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. It makes investments within the healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008, which represents investments in senior housing operations, and (vi) owning healthcare operations.
45GF Score

Get the complete analysis for GBCS

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.25
Price
$2.14
GF Value